Výsledky vyhledávání - "Petersdorf, Ew"

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Autor: Petersdorf EW, the International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Publikováno v: International journal of Immunogenetics

The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non HLA genetics of the transplantation barrier. The Working Group is comprised of experts in the fields of histocompatibility and im

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=snsf_p3_pubs::17a8616d8cbdee076f6428e46c447b9f

Zobrazit plný text záznamu

Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation

Autor: Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW, International Histocompatibility Working Group in Hematopoietic Cell Transplantation.

Publikováno v: Biology of blood and marrow transplantation 19 (2013): 1197–1203.
info:cnr-pdr/source/autori:Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation./titolo:Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation./doi:/rivista:Biology of blood and marrow transplantation/anno:2013/pagina_da:1197/pagina_a:1203/intervallo_pagine:1197–1203/volume:19

The significance of patient and donor ethnicity on risk of acute graft-versus-host disease (GVHD) and disease relapse after unrelated donor hematopoietic cell transplantation (HCT) is not known. A total of 4335 patient-donor pairs from the Internatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::19965e61cade0aae43678c0f98355e23
http://www.cnr.it/prodotto/i/281682

Zobrazit plný text záznamu

16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Autor: Petersdorf, Ew, Malkki, M, Hsu, K, Bardy, P, Cesbron, A, Dickinson, A, Dubois, V, Fleischhauer, K, Kawase, T, Madrigal, A, Morishima, Y, Shaw, B, Spellman, S, Spierings, E, Stern, M, Tiercy, Jm, Velardi, Andrea, Gooley, T, International Histocompatibility Working Group in Hematopoietic Cell Transplantation

Publikováno v: International Journal of Immunogenetics
International Journal of Immunogenetics, Wiley, 2012, 40 (1), pp.2-10. ⟨10.1111/iji.12022⟩
International Journal of Immunogenetics, Vol. 40, No 1 (2013) pp. 2-10

International audience; The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non-HLA genetics of the transplantation barrier. The Working Group is comprised of experts in the fields of h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265c9abc81adf9e932ffc5e3830776a5
https://www.hal.inserm.fr/inserm-03349745

Zobrazit plný text záznamu

Secondary T-Cell Lymphoproliferation after Marrow Transplantation

Autor: Mary M. Zutter, Thomas Ed, Martin Pj, Petersdorf Ew, Hackman Rc, Kidd Pg, Loughran Tp, Ashley Rl, Durnam Dm

Publikováno v: American Journal of Clinical Pathology. 94:714-721

Secondary lymphoproliferative syndromes in immunosuppressed patients have been characterized as polyclonal or monoclonal B-lineage disorders nearly always associated with Epstein-Barr virus (EBV) infection. The authors now report three patients with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddbcb1c086cb88e1d293c3811eb58379
https://doi.org/10.1093/ajcp/94.6.714

Zobrazit plný text záznamu

Autor: BALDUZZI A, GOOLEY T, ANASETTI C, SANDERS JE, MARTIN PJ, PETERSDORF EW, APPELBAUM FR, BUCKNER CD, MATTHEWS D, STORB R, SULLIVAN KM, HANSEN JA

Publikováno v: Blood. 86(8)

Eighty-eight children 0.5 to 17 years of age (median, 9 years of age) received an unrelated donor marrow transplant for treatment of chronic myeloid leukemia (CML; n = 16), acute lymphoblastic leukemia (ALL) in first or second remission (9 = 15) or m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5c47d209e1fd01c8136112c5e1077731
https://pubmed.ncbi.nlm.nih.gov/7579422

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání